Title : Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.

Pub. Date : 2020 Feb

PMID : 31300870






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
2 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
3 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
4 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
5 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
6 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
7 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens
8 CD26/DPP4 plays a fundamental role in the regulation of blood glucose levels by inactivating insulinotropic incretins and CD26/DPP4 inhibitors are thus routinely used in diabetes mellitus type 2 therapy to improve glucose tolerance. Glucose dipeptidyl peptidase 4 Homo sapiens